Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 36 of 36 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Affinergy LLC | Activity: Research and Development | Company Description Affinergy develops diagnostic tools for rare and difficult to diagnose diseases. Affinergy's development programs include rapid assays for proteins, drugs, cells and small molecules. | Location Durham | |
Company Alcon Research LLC | Activity: Research and Development | Company Description Alcon discovers, develops and commercializes first-in-class therapies for the treatment of patients with glaucoma, dry eye, retinal diseases and other diseases of the eye. | Location Durham | |
Company Altis BioSystems Inc. | Activity: Research and Development | Company Description Altis Biosystems has developed a patented stem cell platform that recreates the human intestinal epithelium, in a high-throughput format, for compound screening and microbiome research for biopharmaceutical companies. | Location Durham | |
Company Atrium Health Division of Therapeutic Research and Development | Activity: Research and Development | Company Description The Division of Therapeutic Research and Development at Atrium Health conducts clinical studies, patient-focused translational research and outcomes research. | Location Charlotte | |
Company Autonomous Milks | Activity: Research and Development | Company Description Autonomous Milks is developing mammary cell culture technologies to produce human and bovine milk in a cell-based manufacturing system, with potential applications in food, nutrition and cosmetic markets. | Location Hillsborough | |
Company BASF Agricultural Solutions (RTP) | Activity: Research and Development | Company Description BASF's Agricultural Solutions division conducts seeds, traits and plant biotechnology research with a focus on yield and quality traits in major crops. Its RTP campus also houses a bee care center. | Location Research Triangle Park | |
Company BioAesthetics Corporation | Activity: Research and Development | Company Description BioAesthetics Corporation is developing biomaterials, including the NACgraft, a nipple areolar complex graft to be used in regenerating the nipple-areolar complex for mastectomy patients. | Location Durham | |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is co-located with its sister company, the Carolina BioOncology Institute. | Location Huntersville | |
Company Biorg Inc. | Activity: Research and Development | Company Description Biorg is developing and commercializing organoid technology for use in life science applications such as diagnostics, drug screenings and toxicology. | Location Winston-Salem | |
Company BioRxn LLC | Activity: Research and Development | Company Description BioRxn develops NMR-based metabolomic technology, including bioreactor and artificial liver systems, for non-invasive monitoring of metabolic biomarkers. BioRxn also provides conventional metabolomic services. | Location Chapel Hill | |
Company Bioventus LLC | Activity: Research and Development | Company Description Bioventus develops and markets orthobiologic solutions for musculoskeletal healing and regeneration. The Innovations For Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. | Location Durham | |
Company Cell Microsystems Inc. | Activity: Research and Development | Company Description Cell Microsystems develops, manufactures, and markets products for single cell workflows including CRISPR gene editing, stem cell research, organoid studies, cell line development and antibody discovery. | Location Durham | |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Chapel Hill | |
Company Claradele Pharmaceuticals Inc. | Activity: Research and Development | Company Description Claradele Pharmaceuticals is developing an immunotherapy product to treat melanoma. | Location Winterville | |
Company CorneaGen Inc. | Activity: Research and Development | Company Description CorneaGen provides corneal endothelial cells for transplantation, as well as related supplies and devices. It is an FDA-registered human tissue establishment. | Location Winston-Salem | |
Company CytexOrtho | Activity: Research and Development | Company Description CytexOrtho develops bio-artificial devices to treat osteoarthritis and other musculoskeletal diseases. | Location Durham | |
Company Enzerna Biosciences Inc. | Activity: Research and Development | Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. | Location Morrisville | |
Company EpiCypher Inc. | Activity: Research and Development | Company Description EpiCypher develops and manufactures novel products and services for epigenetics and chromatin biology, focused on enabling drug discovery research and development. | Location Durham | |
Company GEM Tox Labs | Activity: Research and Development | Company Description GEM Tox Labs conducts research focused on the role of MicroRNA molecules in cancer. | Location Greenville | |
Company Genoverde Biosciences Inc. | Activity: Research and Development | Company Description Genoverde Biosciences is developing improved varieties of industrial hemp through traditional breeding and genetic engineering technologies for agricultural and biomedical applications. | Location Raleigh | |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill | |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham | |
Company IngateyGen LLC | Activity: Research and Development | Company Description IngateyGen is an early stage Ag Biotech company using CRISPR genome editing technology to develop an allergen reduced peanut, a peanut with modified oil profile and an ultra high protein peanut for improved safety and nutritional value to consumers. | Location Research Triangle Park | |
Company Innovasive Environmental LLC | Activity: Research and Development | Company Description Innovasive Environmental develops environmentally-friendly, species-specific herbicides based on a species’ genome. | Location Black Mountain | |
Company Insoma Bio Inc. | Activity: Research and Development | Company Description InSomaBio is developing recombinant, protein-based materials to solve problems in tissue engineering and regenerative medicine. | Location Durham | |
Company KeraNetics LLC | Activity: Research and Development | Company Description KeraNetics develops keratin-based biomaterials to be used for wound care and tissue regeneration. | Location Winston-Salem | |
Company LifeNet Health | Activity: Research and Development | Company Description LifeNet Health provides transplant solutions, including cellular therapy research, organ procurement and bio-implant. The North Carolina facility isolates liver cells and adult stem cells for applications in drug discovery and toxicity testing. | Location Research Triangle Park | |
Company Mastezellen Bio Inc. | Activity: Research and Development | Company Description Mastezellen Bio is developing therapeutics for the treatment of diseases and disorders with mast cell involvement. | Location Research Triangle Park | |
Company Merakris Therapeutics Inc. | Activity: Research and Development | Company Description Merakris Therapeutics develops biotherapeutic technologies derived from stem cells that promote homeostasis in damaged tissue. | Location Research Triangle Park | |
Company NovaCyte LLC | Activity: Research and Development | Company Description NovaCyte isolates cells from donor corneas to grow replacement corneal tissue on a scaffold as a bioengineered equivalent to the current standard of care. | Location Winston-Salem | |
Company Path BioAnalytics Inc. | Activity: Research and Development | Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. | Location Durham | |
Company Plakous Therapeutics Inc. | Activity: Research and Development | Company Description Plakous Therapeutics developed a cell-free placenta extract to prevent necrotizing enterocolitis in premature babies. The cytokines and growth factors purified in the product have anti-inflammatory, regenerative, and immunomodulatory properties analogous to mid-pregnancy amniotic fluid. | Location Winston-Salem | |
Company Precise Bio Inc. | Activity: Research and Development | Company Description Precise Bio grows live and vital complicated organs for transplant using 3D bio-printing. | Location Winston-Salem | |
Company RTT Medical | Activity: Research and Development | Company Description RTT Medical provides regenerative tissue technologies for wound management. | Location Winston-Salem | |
Company Sumitomo Pharma America Inc. (Cary) | Activity: Research and Development | Company Description Sumitomo Pharma America develops regenerative therapeutics for rare diseases such as congenital athymia. | Location Cary | |
Company United Therapeutics Corp. (RTP HQ) | Activity: Research and Development | Company Description United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer. | Location Research Triangle Park |